Cargando…
Targeting cancer cachexia: Molecular mechanisms and clinical study
Cancer cachexia is a complex systemic catabolism syndrome characterized by muscle wasting. It affects multiple distant organs and their crosstalk with cancer constitute cancer cachexia environment. During the occurrence and progression of cancer cachexia, interactions of aberrant organs with cancer...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464063/ https://www.ncbi.nlm.nih.gov/pubmed/36105371 http://dx.doi.org/10.1002/mco2.164 |
_version_ | 1784787503162589184 |
---|---|
author | Wang, Yong‐Fei An, Zi‐Yi Lin, Dong‐Hai Jin, Wei‐Lin |
author_facet | Wang, Yong‐Fei An, Zi‐Yi Lin, Dong‐Hai Jin, Wei‐Lin |
author_sort | Wang, Yong‐Fei |
collection | PubMed |
description | Cancer cachexia is a complex systemic catabolism syndrome characterized by muscle wasting. It affects multiple distant organs and their crosstalk with cancer constitute cancer cachexia environment. During the occurrence and progression of cancer cachexia, interactions of aberrant organs with cancer cells or other organs in a cancer cachexia environment initiate a cascade of stress reactions and destroy multiple organs including the liver, heart, pancreas, intestine, brain, bone, and spleen in metabolism, neural, and immune homeostasis. The role of involved organs turned from inhibiting tumor growth into promoting cancer cachexia in cancer progression. In this review, we depicted the complicated relationship of cancer cachexia with the metabolism, neural, and immune homeostasis imbalance in multiple organs in a cancer cachexia environment and summarized the treatment progress in recent years. And we discussed the molecular mechanism and clinical study of cancer cachexia from the perspective of multiple organs metabolic, neurological, and immunological abnormalities. Updated understanding of cancer cachexia might facilitate the exploration of biomarkers and novel therapeutic targets of cancer cachexia. |
format | Online Article Text |
id | pubmed-9464063 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94640632022-09-13 Targeting cancer cachexia: Molecular mechanisms and clinical study Wang, Yong‐Fei An, Zi‐Yi Lin, Dong‐Hai Jin, Wei‐Lin MedComm (2020) Reviews Cancer cachexia is a complex systemic catabolism syndrome characterized by muscle wasting. It affects multiple distant organs and their crosstalk with cancer constitute cancer cachexia environment. During the occurrence and progression of cancer cachexia, interactions of aberrant organs with cancer cells or other organs in a cancer cachexia environment initiate a cascade of stress reactions and destroy multiple organs including the liver, heart, pancreas, intestine, brain, bone, and spleen in metabolism, neural, and immune homeostasis. The role of involved organs turned from inhibiting tumor growth into promoting cancer cachexia in cancer progression. In this review, we depicted the complicated relationship of cancer cachexia with the metabolism, neural, and immune homeostasis imbalance in multiple organs in a cancer cachexia environment and summarized the treatment progress in recent years. And we discussed the molecular mechanism and clinical study of cancer cachexia from the perspective of multiple organs metabolic, neurological, and immunological abnormalities. Updated understanding of cancer cachexia might facilitate the exploration of biomarkers and novel therapeutic targets of cancer cachexia. John Wiley and Sons Inc. 2022-09-10 /pmc/articles/PMC9464063/ /pubmed/36105371 http://dx.doi.org/10.1002/mco2.164 Text en © 2022 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Wang, Yong‐Fei An, Zi‐Yi Lin, Dong‐Hai Jin, Wei‐Lin Targeting cancer cachexia: Molecular mechanisms and clinical study |
title | Targeting cancer cachexia: Molecular mechanisms and clinical study |
title_full | Targeting cancer cachexia: Molecular mechanisms and clinical study |
title_fullStr | Targeting cancer cachexia: Molecular mechanisms and clinical study |
title_full_unstemmed | Targeting cancer cachexia: Molecular mechanisms and clinical study |
title_short | Targeting cancer cachexia: Molecular mechanisms and clinical study |
title_sort | targeting cancer cachexia: molecular mechanisms and clinical study |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464063/ https://www.ncbi.nlm.nih.gov/pubmed/36105371 http://dx.doi.org/10.1002/mco2.164 |
work_keys_str_mv | AT wangyongfei targetingcancercachexiamolecularmechanismsandclinicalstudy AT anziyi targetingcancercachexiamolecularmechanismsandclinicalstudy AT lindonghai targetingcancercachexiamolecularmechanismsandclinicalstudy AT jinweilin targetingcancercachexiamolecularmechanismsandclinicalstudy |